Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer's Disease

被引:22
|
作者
Thawkar, Baban S. [1 ]
Kaur, Ginpreet [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol, VL Mehta Rd, Mumbai 400056, Maharashtra, India
关键词
Metals; Okadaic acid; The habenula; Neurodegeneration; Cognitive impairment agents; Cigarette smoke extract; Glutaminergic and cholinergic pathways;
D O I
10.1007/s12640-021-00343-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Drug discovery and development for Alzheimer's disease (AD) are complex and challenging due to the higher failure rate in the drug development process. The overproduction and deposition of A beta senile plaque and intracellular neurofibrillary tangle (NFT) formation are well-recognized diagnostic hallmarks of AD. Numerous transgenic models of Alzheimer's disease have restrictions on cost-effectiveness and time in the preclinical setup. Zebrafish has emerged as an excellent complementary model for neurodegenerative research due to simpler organisms with robust, clearly visible behavior forms. Glutaminergic and cholinergic pathways responsible for learning and memory are present in zebrafish and actively participate in the transmission process. Therefore, it is imperative to study neurotoxic agents' mechanisms that induce dysfunction of memory, learning, and neurons in the zebrafish. This review illustrates the in-depth molecular mechanism of several neurotoxic agents such as okadaic acid, cigarette smoke extract, and metals to produce cognitive deficits or neurodegeneration similar to mammals. These updates would determine an ideal and effective neurotoxic agent for producing AD pathophysiology in the zebrafish brain for preclinical screening.
引用
收藏
页码:949 / 965
页数:17
相关论文
共 50 条
  • [31] Targeting Thrombin: An Inflammatory Neurotoxin in Alzheimer's Disease
    Grammas, Paula
    Martinez, Joseph M.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S537 - S544
  • [32] Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease
    Pablo, J.
    Banack, S. A.
    Cox, P. A.
    Johnson, T. E.
    Papapetropoulos, S.
    Bradley, W. G.
    Buck, A.
    Mash, D. C.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (04): : 216 - 225
  • [33] Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
    Qiao, Juhui
    Zhao, Yuchu
    Liu, Ying
    Zhang, Siyu
    Zhao, Wenxue
    Liu, Shichao
    Liu, Meichen
    MOLECULAR MEDICINE REPORTS, 2022, 25 (06)
  • [34] Transdifferentiation: A Novel Tool for Disease Modeling and Translational Applications in Alzheimer's Disease
    Chou, Ching-Chieh
    Vest, Ryan
    Prado, Miguel A.
    Wilson-Grady, Joshua
    Paulo, Joao A.
    Shibuya, Yohei
    Moran-Losada, Patricia
    Lee, Ting-Ting
    Luo, Jian
    Gygi, Steven P.
    Kelly, Jeffery W.
    Finley, Daniel P.
    Wernig, Marius
    Wyss-Coray, Tony
    Frydman, Judith
    ANNALS OF NEUROLOGY, 2023, 94 : S205 - S206
  • [35] Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson's Disease
    Chiu, Ya-Jen
    Lin, Chih-Hsin
    Lin, Chung-Yin
    Yang, Pei-Ning
    Lo, Yen-Shi
    Chen, Yu-Chieh
    Chen, Chiung-Mei
    Wu, Yih-Ru
    Yao, Ching-Fa
    Chang, Kuo-Hsuan
    Lee-Chen, Guey-Jen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [36] Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement
    Hu, XiaoLong
    Song, Qi
    Li, Xin
    Li, DanDan
    Zhang, Qiao
    Meng, WeiHong
    Zhao, QingChun
    NEUROPHARMACOLOGY, 2017, 117 : 352 - 363
  • [37] Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?
    Pohanka, Miroslav
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (14) : 1432 - 1441
  • [38] Flotillin: A Promising Biomarker for Alzheimer's Disease
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Shaikh, Mohd. Farooq
    Piperi, Christina
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (02):
  • [39] Promising agents for treating Alzheimer's disease
    Simonson, W
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 : S11 - S16
  • [40] A promising new treatment for Alzheimer's disease?
    O'Brien, John T.
    LANCET NEUROLOGY, 2008, 7 (09): : 768 - 769